EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.3.2.6 | (2R)-2-([4-[4-(thiophen-2-yl)benzyl]phenoxy]methyl)piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-([4-[4-(thiophen-3-yl)benzyl]phenoxy]methyl)piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-([4-[4-(thiophen-3-yl)phenoxy]phenoxy]methyl)piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[(4-phenoxyphenoxy)methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[[4-(4-chlorobenzyl)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]-1-(1,2,4-oxadiazol-2(3H)-ylmethyl)piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[[4-(4-fluorophenoxy)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2R)-2-[[4-(biphenyl-4-yloxy)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2S)-2-([4-[4-(trifluoromethyl)phenoxy]phenoxy]methyl)piperidine | - |
Homo sapiens | |
3.3.2.6 | (2S)-2-[(4-benzylphenoxy)methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2S)-2-[(4-phenoxyphenoxy)methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2S)-2-[[4-(4-chlorobenzyl)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | (2S)-2-[[4-(biphenyl-4-yloxy)phenoxy]methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | 1-benzyl-3-[(4-benzylphenoxy)methyl]piperazine | - |
Homo sapiens | |
3.3.2.6 | 2-[(4-benzylphenoxy)methyl]piperazine | - |
Homo sapiens | |
3.3.2.6 | 2-[(4-benzylphenoxy)methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | 2-[(4-phenoxyphenoxy)methyl]piperidine | - |
Homo sapiens | |
3.3.2.6 | 3-[(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]propanoic acid | - |
Homo sapiens | |
3.3.2.6 | 4-[(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]butanoic acid | - |
Homo sapiens | |
3.3.2.6 | 4-[(2S)-2-([4-[4-(thiophen-3-yl)benzyl]phenoxy]methyl)piperidin-1-yl]butanoic acid | - |
Homo sapiens | |
3.3.2.6 | 4-[(2S)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]butanoic acid | - |
Homo sapiens | |
3.3.2.6 | additional information | leukotriene A4 inhibitors based on piperidine and piperazine scaffolds, overview | Homo sapiens | |
3.3.2.6 | [(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]acetic acid | - |
Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.3.2.6 | leukotriene A4 + H2O | Homo sapiens | - |
leukotriene B4 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.3.2.6 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.3.2.6 | blood | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.3.2.6 | leukotriene A4 + H2O | - |
Homo sapiens | leukotriene B4 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.3.2.6 | leukotriene A4 hydrolase | - |
Homo sapiens |
3.3.2.6 | LTA4 hydrolase | - |
Homo sapiens |
3.3.2.6 | LTA4H | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.3.2.6 | 0.0000069 | - |
- |
Homo sapiens | (2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]-1-(1,2,4-oxadiazol-2(3H)-ylmethyl)piperidine | |
3.3.2.6 | 0.000044 | - |
- |
Homo sapiens | (2R)-2-[(4-phenoxyphenoxy)methyl]piperidine | |
3.3.2.6 | 0.000048 | - |
- |
Homo sapiens | (2S)-2-[(4-phenoxyphenoxy)methyl]piperidine | |
3.3.2.6 | 0.000049 | - |
- |
Homo sapiens | 4-[(2S)-2-([4-[4-(thiophen-3-yl)benzyl]phenoxy]methyl)piperidin-1-yl]butanoic acid | |
3.3.2.6 | 0.000053 | - |
- |
Homo sapiens | 4-[(2S)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]butanoic acid | |
3.3.2.6 | 0.000056 | - |
- |
Homo sapiens | (2R)-2-([4-[4-(thiophen-2-yl)benzyl]phenoxy]methyl)piperidine | |
3.3.2.6 | 0.00006 | - |
- |
Homo sapiens | (2R)-2-([4-[4-(thiophen-3-yl)benzyl]phenoxy]methyl)piperidine | |
3.3.2.6 | 0.00007 | - |
- |
Homo sapiens | 2-[(4-phenoxyphenoxy)methyl]piperidine | |
3.3.2.6 | 0.000093 | - |
- |
Homo sapiens | (2S)-2-([4-[4-(trifluoromethyl)phenoxy]phenoxy]methyl)piperidine | |
3.3.2.6 | 0.000093 | - |
- |
Homo sapiens | (2R)-2-([4-[4-(thiophen-3-yl)phenoxy]phenoxy]methyl)piperidine | |
3.3.2.6 | 0.000094 | - |
- |
Homo sapiens | (2S)-2-[(4-benzylphenoxy)methyl]piperidine | |
3.3.2.6 | 0.000096 | - |
- |
Homo sapiens | (2S)-2-[[4-(biphenyl-4-yloxy)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.000106 | - |
- |
Homo sapiens | 4-[(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]butanoic acid | |
3.3.2.6 | 0.00011 | - |
- |
Homo sapiens | (2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.000114 | - |
- |
Homo sapiens | (2R)-2-[[4-(biphenyl-4-yloxy)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.000134 | - |
- |
Homo sapiens | 2-[(4-benzylphenoxy)methyl]piperidine | |
3.3.2.6 | 0.000174 | - |
- |
Homo sapiens | (2R)-2-[[4-(4-fluorophenoxy)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.000212 | - |
- |
Homo sapiens | 3-[(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]propanoic acid | |
3.3.2.6 | 0.000315 | - |
- |
Homo sapiens | (2S)-2-[[4-(4-chlorobenzyl)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.000342 | - |
- |
Homo sapiens | 2-[(4-benzylphenoxy)methyl]piperazine | |
3.3.2.6 | 0.000438 | - |
- |
Homo sapiens | (2R)-2-[[4-(4-chlorobenzyl)phenoxy]methyl]piperidine | |
3.3.2.6 | 0.00066 | - |
- |
Homo sapiens | 1-benzyl-3-[(4-benzylphenoxy)methyl]piperazine | |
3.3.2.6 | 0.00088 | - |
- |
Homo sapiens | [(2R)-2-[[4-(4-chlorophenoxy)phenoxy]methyl]piperidin-1-yl]acetic acid |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.3.2.6 | metabolism | leukotriene A4 hydrolase is a key enzyme in the leukotriene pathway, which hydrolyzes leukotriene A4 to leukotriene B4, a proinflammatory mediator | Homo sapiens |